UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas

Annals of oncology, 2020-08, Vol.31 (8), p.1011-1020

2020

Volltextzugriff (PDF)

The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia

Leukemia, 2015-01, Vol.29 (1), p.169-176

2015

Volltextzugriff (PDF)

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells

Leukemia, 2013-01, Vol.27 (1), p.66-74

2013

Volltextzugriff (PDF)

Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors

Oncogene, 2017-02, Vol.36 (8), p.1058-1068

2017

Volltextzugriff (PDF)

Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice

Leukemia, 2016-01, Vol.30 (1), p.190-199

2016

Volltextzugriff (PDF)

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma

Annals of oncology, 2023-03, Vol.34 (3), p.275-288

2023

Volltextzugriff (PDF)

Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

Leukemia, 2013-04, Vol.27 (4), p.968-971

2013

Volltextzugriff (PDF)

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Annals of oncology, 2022-10, Vol.33 (10), p.1029-1040

2022

Volltextzugriff (PDF)

The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading

Leukemia, 2015-01, Vol.29 (1), p.241-244

2015

Volltextzugriff (PDF)

The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom’s Macroglobulinemia

Leukemia, 2015-01, Vol.29 (1), p.169-176

2015

Volltextzugriff (PDF)

539 BET Bromodomain Inhibition Targets Both c-Myc and IL7R in Acute Lymphoblastic Leukemia

European journal of cancer (1990), 2012-11, Vol.48, p.166-166

2012

Volltextzugriff (PDF)

NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL

Hematological oncology, 2017-06, Vol.35 (S2), p.135-136

2017

Volltextzugriff (PDF)

482 Relationship Between Tumor MET Expression and Clinical Outcomes in Cancer Patients Treated with Tivantinib

European journal of cancer (1990), 2012-11, Vol.48, p.149-149

2012

Volltextzugriff (PDF)

Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway

Cell, 1996-02, Vol.84 (3), p.431-442

1996

Volltextzugriff (PDF)

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas

Haematologica (Roma), 2010-12, Vol.95 (12), p.2056-2062

2010

Volltextzugriff (PDF)

ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ

The Journal of biological chemistry, 2001-01, Vol.276 (1), p.287-297

2001

Volltextzugriff (PDF)

OA031-04. Impairment of HIV-1-specific CD8+ T cell function by soluble epithelial adhesion molecules

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.O22-O22, Article O22

2009

Volltextzugriff (PDF)

Essential Role for TRPC5 in Amygdala Function and Fear-Related Behavior

Cell, 2009-05, Vol.137 (4), p.761-772

2009

Volltextzugriff (PDF)

P2.10-04 Immunologic Subtype of Small Cell Lung Carcinoma Dictates Susceptibility to NK Cell-Mediated Cytotoxicity

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S147

2022

Volltextzugriff (PDF)

Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets

Cell death and differentiation, 2017-02, Vol.24 (2), p.251-262

2017

Volltextzugriff (PDF)

Splendore-Hoeppli phenomenon

Archives of pathology & laboratory medicine (1976), 2001-11, Vol.125 (11), p.1515-1516

2001

Volltextzugriff (PDF)

Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer

Annals of oncology, 2024-06

2024

Volltextzugriff (PDF)

P2.15-01 Priming SCLC Vasculature to Facilitate NK Cell Attack

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S374

2023

Volltextzugriff (PDF)

P2.04-27 Clinical Implementation of Multiplex Immunofluorescence to Characterize Tumor Immune Status in Lung Cancer Patients

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S718-S719

2019

Volltextzugriff (PDF)

OA14.04 Three-Year Outcomes with First-Line Pembrolizumab, in Patients with Non-Small-Cell Lung Cancer and A PD-L1 Tumor Proportion Score >90

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S77

2023

Volltextzugriff (PDF)

1 – 25 von 1.054

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(953)
Mit Volltextzugriff
(974)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas

The WHIM-like CXCR4(S338X) somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells

Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors

Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma

Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading

The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom’s Macroglobulinemia

539 BET Bromodomain Inhibition Targets Both c-Myc and IL7R in Acute Lymphoblastic Leukemia

NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL

482 Relationship Between Tumor MET Expression and Clinical Outcomes in Cancer Patients Treated with Tivantinib

Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas

ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ

OA031-04. Impairment of HIV-1-specific CD8+ T cell function by soluble epithelial adhesion molecules

Essential Role for TRPC5 in Amygdala Function and Fear-Related Behavior

P2.10-04 Immunologic Subtype of Small Cell Lung Carcinoma Dictates Susceptibility to NK Cell-Mediated Cytotoxicity

Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets

Splendore-Hoeppli phenomenon

Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer

P2.15-01 Priming SCLC Vasculature to Facilitate NK Cell Attack

P2.04-27 Clinical Implementation of Multiplex Immunofluorescence to Characterize Tumor Immune Status in Lung Cancer Patients

OA14.04 Three-Year Outcomes with First-Line Pembrolizumab, in Patients with Non-Small-Cell Lung Cancer and A PD-L1 Tumor Proportion Score >90

Aktive Filter

Suchergebnisse filtern